Article

Shifting The Paradigm for Retinal Disease Management

Trouble viewing this PDF?

Click to download

If you are unable to download this pdf file, please try again in another browser.


Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
Related Content
FDA approves revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2
March 6th 2025

FDA approves revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

The human impact of geographic atrophy
March 6th 2025

The human impact of geographic atrophy

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

(Image credit: AdobeStock/Ekaterina Pokrovsky)
March 5th 2025

Women’s eye health: The Fred Hollows Foundation's call for change this International Women’s Day

The search for an antifibrotic drug for use with pediatric glaucoma devices
March 5th 2025

The search for an antifibrotic drug for use with pediatric glaucoma devices

© 2025 MJH Life Sciences

All rights reserved.